Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

about

Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

Item

http://www.wikidata.org/entity/Q38697074

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

@en

type

Item

label

Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

@en

prefLabel

Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

@en

P1476

Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.

@en

P2093

Aamer Abbas

http://www.w3.org/2001/XMLSchema#string

Mateo Porres-Aguilar

http://www.w3.org/2001/XMLSchema#string

Oscar C Muñoz

http://www.w3.org/2001/XMLSchema#string

P2860

Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.

The role of the funny current in pacemaker activity.

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.

Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.

Rest heart rate and life expectancy.

P2888

s11886-015-0689-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-015-0689-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012971448

http://www.w3.org/2001/XMLSchema#string

P698

26768739

http://www.w3.org/2001/XMLSchema#string